Literature DB >> 5526076

[Supplemental hormone treatment of operable breast neoplasms].

P N Ehlers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5526076     DOI: 10.1007/bf01259050

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  11 in total

1.  [FURTHER STUDIES ON THE PRACTICAL SIGNIFICANCE OF THE EXAMINATION OF CELL NUCLEUS MORPHOLOGY IN BREAST CANCER].

Authors:  P N EHLERS; H HIENZ; C HOCHBERG; M NURI
Journal:  Chirurg       Date:  1964-06       Impact factor: 0.955

2.  [ON THE CELL NUCLEUS MORPHOLOGICAL SEX DETERMINAION BY TUMORS, ESPECIALLY MAMMARY CARCINOMAS].

Authors:  H A HIENZ
Journal:  Wien Klin Wochenschr       Date:  1964-12-04       Impact factor: 1.704

3.  [THE SURGICAL CLINIC, UNIVERSITY OF HEIDELBERG, COLLECTIVE EXPERIENCE IN THE TREATMENT OF MAMMARY CARCINOMA WITH PARTICULAR CONSIDERATION FOR THE SEX CHROMATIN].

Authors:  P N EHLERS; M NURI; C HOCHBERG
Journal:  Wien Klin Wochenschr       Date:  1964-12-04       Impact factor: 1.704

4.  Clinical-cytological correlations of mammary carcinoma based upon sex-chromatin counts; a preliminary study.

Authors:  V M KIMEL
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

5.  [Cell nuclear morphological sex in breast and prostate carcinoma].

Authors:  H A HIENZ; P N EHLERS
Journal:  Klin Wochenschr       Date:  1957-10-01

6.  [Cell nucleus morphological sex and hormonal influenceability of breast carcinoma].

Authors:  P N EHLERS; H A HIENZ
Journal:  Langenbecks Arch Klin Chir Ver Dtsch Z Chir       Date:  1958

7.  The morphology of the nerve cell nucleus, according to sex.

Authors:  M L BARR; L F BERTRAM; H A LINDSAY
Journal:  Anat Rec       Date:  1950-07

8.  [Evaluation of lymph node metastases for determination of the cell nucleus morphological gender in breast carcinoma].

Authors:  K Hochberg; M Nuri
Journal:  Chirurg       Date:  1966-02       Impact factor: 0.955

9.  [Endocrinic management of metastasizing breast carcinoma in the female].

Authors:  H Nowakowski
Journal:  Internist (Berl)       Date:  1968-09       Impact factor: 0.743

10.  [The current status of endocrine therapy in the palliative treatment of the metastasizing breast carcinoma in women].

Authors:  H Nowakowski
Journal:  Chirurg       Date:  1968-06       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.